Disorders of the central nervous system are the most significant disease burden in high income countries and is expected to grow substantially in other regions of the world, including Asia, as the standard of living increases.
Product range
More information about our products is available by clicking on the names below.
| Brand Name | Generic Name |
|---|---|
| Carbocaine | mepivacaine |
| Citanest | prilocaine |
| Diprivan | propofol |
| EMLA | Eutectic Mixture of Lidocaine and Prilocaine |
| Inderal, Inderal LA, Avlocardyl, Avlocardyl retard, Dociton, Inderalici, Sumial | propranolol hydrochloride |
| Marcaine/Sensorcaine | bupivacaine |
| Mysoline, Mylepsinum | primidone |
| Naropin | ropivacaine |
| Seroquel | quetiapine |
| Vivalan | viloxazine hydrocholoride |
| Xylocaine | lidocaine |
| Zomig, Zomig Rapimelt, Zomig Nasal Spray, AscoTop, Zomigon | zolmitriptan |
Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.
Not signed in
Page tools
Share price
- London
-
29.18 GBP - New York
-
44.31 USD
- Stockholm
-
313.00 SEK
At 16-Mar-2010 03:08 GMT
Detailed share priceContact us
Contact us
On the issues
We communicate openly on key issues that affect or concern our stakeholders, including:
